Innovus Pharmaceuticals Inc. (fka INNV)

[ShawnP123]

Introducing new products will continue to drain their cash. Their distribution channel is beyond human. It's going top take money and time to build.

Next, they haven't reduced their operating costs and will continue to take bonus.

Finally, if this stock was so good, you would think they would invest their own money and buy on the open market.

The current companies which they are paying to promote their stock, will eventually give up rather than tarnish their reputation unless things change.